GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Oncodesign Precision Medicine SA (XPAR:ALOPM) » Definitions » Other Current Receivables

Oncodesign Precision Medicine (XPAR:ALOPM) Other Current Receivables

: €0.74 Mil (As of Jun. 2022)
View and export this data going back to 2022. Start your Free Trial

Oncodesign Precision Medicine's Other Current Receivables for the quarter that ended in Jun. 2022 was €0.74 Mil.

Oncodesign Precision Medicine's quarterly Other Current Receivables declined from Dec. 2020 (€1.73 Mil) to Dec. 2021 (€1.20 Mil) but then stayed the same from Dec. 2021 (€1.20 Mil) to Jun. 2022 (€0.74 Mil).

Oncodesign Precision Medicine's annual Other Current Receivables increased from . 20 (€0.00 Mil) to Dec. 2020 (€1.73 Mil) but then declined from Dec. 2020 (€1.73 Mil) to Dec. 2021 (€1.20 Mil).


Oncodesign Precision Medicine Other Current Receivables Historical Data

The historical data trend for Oncodesign Precision Medicine's Other Current Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Oncodesign Precision Medicine Annual Data
Trend Dec20 Dec21
Other Current Receivables
1.73 1.20

Oncodesign Precision Medicine Semi-Annual Data
Dec20 Dec21 Jun22
Other Current Receivables 1.73 1.20 0.74

Oncodesign Precision Medicine Other Current Receivables Calculation

GuruFocus uses a standardized financial statement format for all companies. GuruFocus lists Accounts Receivable, Notes Receivable , Loans Receivable and Other Current Receivables under the "Total Receivables" section.


Oncodesign Precision Medicine Other Current Receivables Related Terms

Thank you for viewing the detailed overview of Oncodesign Precision Medicine's Other Current Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.


Oncodesign Precision Medicine (XPAR:ALOPM) Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
18 rue Jean Mazen, Dijon, FRA, 21000
Oncodesign Precision Medicine SA is a biopharmaceutical company specialised in precision medicine. Its mission is to provide patients with effective diagnostic and therapeutic solutions for resistant and metastatic cancers.

Oncodesign Precision Medicine (XPAR:ALOPM) Headlines

No Headlines